Navigation Links
ORTHOWORLD(R) Announces FDA Official to Serve as Panelist at Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC(R))
Date:4/12/2013

CHAGRIN FALLS, Ohio, April 12, 2013 /PRNewswire/ -- ORTHOWORLD, Inc., leading producer of strategic intelligence for the orthopaedic industry, announced its education curriculum for OMTEC 2013, to be held June 12-13 in Chicago.

OMTEC's keynote panel discussion, The State and Future of U.S. FDA, brings together regulatory experts to talk about current and future FDA decisions that are impacting all stakeholders within the supply chain, including 510(k) clearance and supplier compliance. Dialogue is aimed at providing high-level actionable advice for orthopaedic device companies, contract manufacturers, investors and others.

A complementary lineup of lectures, including How to Design and Execute a Clinical Trial, Unique Device Identification Compliance, Trends in FDA Recalls and Tools for Qualifying Suppliers, delivers further insights and recommendations to orthopaedic industry professionals amidst intense regulatory scrutiny.

"OMTEC consistently attracts industry achievers," explains April Bright , General Manager of ORTHOWORLD. "Each year I'm amazed, impressed and humbled by OMTEC's supporters. They understand that investments in education and personal relationships yield return, especially in the absence of regulatory, political or economic certainty. Attendees and exhibitors genuinely care about the livelihood of one another and the continued health of the specialty of orthopaedics. OMTEC is proud to be the place they gather to raise the performance bar another notch."

The first and predominant conference of its kind, OMTEC is expected to host nearly 1,000 industry professionals from across the globe. The event website, www.omtecexpo.com, provides complete details on the acclaimed educational lineup, exhibitor listings and confirmed registrants.

ABOUT ORTHOWORLD
Founded in 1992, ORTHOWORLD is a highly specialized publishing firm offering strategic intelligence, integrated advertising and educational conferences exclusively to the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

CONTACT:
Fran Bursic
ORTHOWORLD, Inc.
440.543.2101 (phone)
fran@orthoworld.com 
www.orthoworld.com


'/>"/>
SOURCE ORTHOWORLD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 2016 The global  non-invasive prenatal testing market  is ... report by Grand View Research, Inc. Evolution of prenatal testing in the ... serum screening and invasive diagnostic testing to determine the likelihood of fetal ... the forecast period. Continue Reading ... ...
(Date:12/4/2016)... Blueprint Medicines Corporation (NASDAQ: BPMC ... kinase medicines for patients with genomically defined diseases, ... trial evaluating BLU-285, an investigational medicine for the ... Blueprint Medicines is developing BLU-285 as a potent, ... 90 to 95 percent of patients with SM ...
(Date:12/4/2016)... , Dec. 2, 2016  Former Attorney General of ... , a partner at the law firm of Kahn Swick ... investigation into Lannett Company, Inc. (NYSE: LCI ). ... published an article titled "U.S. Charges in Generic-Drug Probe to ... by the Justice Department, begun about two years ago, now ...
Breaking Medicine Technology:
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... ability of physical therapist assistants, under direct supervision of a licensed physical therapist, ... physical therapy receives a consultation and treatment plan from a licensed physical therapist ...
(Date:12/5/2016)... CHICAGO, IL (PRWEB) , ... December 05, 2016 , ... ... value to the individual looking to buy neoprene knee sleeves for lifting ... activity. The design focuses heavily on two main aspects to provide a higher quality ...
(Date:12/5/2016)... (PRWEB) , ... December 05, ... ... professional calibrations is an excellent way to ensure moisture measurements are consistently ... time-consuming and impractical. , Now, METTLER TOLEDO offers a solution: ...
(Date:12/5/2016)... ... 05, 2016 , ... Z-Medica, LLC, a leading developer and ... American College of Surgeons (ACS) to provide basic bleeding control instructor training to ... course is a pilot program that fulfills the intent of the White House’s ...
(Date:12/4/2016)... , ... December 02, 2016 , ... ... give patients better access to nutraceuticals and help doctors more efficiently manage their ... portal and practice management software platform for Integrative and Functional Medicine. , ...
Breaking Medicine News(10 mins):